Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Pembrolizumab + Cabozantinib for Kidney Cancer
Recruiting1 awardPhase 1 & 2
Aurora, Colorado
This trial is testing a new cancer treatment combining two drugs. The first part will see if the combination is safe and what the best dose is. The second part will test how well the combination works.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.